Standout Papers

Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoc... 1988 2026 2000 2013 552
  1. Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist (1988)
    Raimo Virtanen, Juha‐Matti Savola et al. European Journal of Pharmacology

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Xylazine Adulteration of the Heroin–Fentanyl Drug Supply
2023 Standout
The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family
2021 Standout
2 intermediate papers

Works of Leena Nyman being referenced

CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.
2001
Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist
1988 Standout

Author Peers

Author Last Decade Papers Cites
Leena Nyman 195 215 27 349 24 1.1k
Markku Anttila 119 270 52 377 40 1.3k
Jay Ham 188 137 31 473 12 1.3k
Burnell R. Brown 131 168 29 498 71 1.4k
R. Daniel Mellon 242 56 17 318 16 1.1k
Yukio Horai 130 364 33 206 35 1.3k
P. Maitre 74 68 2 558 47 1.1k
F. O. Holley 73 60 30 299 16 877
Sakari Karhuvaara 248 32 3 250 21 1.1k
M. Michiels 115 107 18 165 25 869
Virginia D. Schmith 130 69 28 453 49 1.1k

All Works

Loading papers...

Rankless by CCL
2026